FDA Cracks Down on Custom-Made Hormones

Jan 09, 2008 By RANDOLPH E. SCHMID, AP Science Writer

(AP) -- Government health officials began cracking down Wednesday on Internet sales of custom-mixed hormones for menopausal women, a market created when doctors deemed prescription estrogen therapy too risky for many patients.



Content from The Associated Press expires 15 days after original publication date. For more information about The Associated Press, please visit www.ap.org .

Explore further: FDA investigates deaths of patients on antipsychotic drug

add to favorites email to friend print save as pdf

Related Stories

WWF urges Romania, Bulgaria to protect wild sturgeon

12 minutes ago

Conservationist group WWF on Tuesday urged Romania and Bulgaria, home to the last viable wild sturgeon populations in the European Union, to protect the species, threatened by illegal fishing and caviar trade.

Mathematical algorithms cut train delays

1 hour ago

Commuters are already seeing a reduction in delays and waiting times thanks to new software able to adapt railway schedules in real time following unforeseen disruptions.

The dissector and the draughtsman

1 hour ago

Between 1831 and 1854, the French anatomist Jean-Marc Bourgery and his compatriot Nicolas-Henri Jacob, a versatile artist, produced a richly illustrated and ground-breaking medical textbook. The "Traité ...

Recommended for you

Protalix signs supply deal with Brazilian govt

13 hours ago

Shares of Protalix BioTherapeutics Inc. jumped in premarket trading Wednesday after the drug developer announced a deal that requires the Brazilian government to buy at least $280 million of the company's Gaucher disease ...

EU fines pharma firms over generics delay (Update)

13 hours ago

(AP)—The European Union has fined Danish pharmaceuticals multinational Lundbeck and several other producers a combined 146 million euros ($195 million) for delaying the market entry of cheaper generic alternatives ...

Investigational drug improves sleep disorder among the blind

Jun 17, 2013

An investigational new drug significantly improved a common and debilitating circadian rhythm sleep disorder that frequently affects people who are completely blind, a multicenter study finds. The results were presented Monday ...

User comments : 0

More news stories